Lead Counsel Battle Heats Up In $1.8B Biotech Sale Suit
A battle is heating up in Delaware Chancery Court over who will lead stockholder litigation alleging the $1.8 billion sale of Emisphere Technologies to Novo Nordisk last year was unfair, with...To view the full article, register now.
Already a subscriber? Click here to view full article